Arkolith/Insider Trading/OCUL/Form 4

Dugel Pravin

See Remarks, DirectorOCULAR THERAPEUTIX, INC (OCUL) · full profile →Form 4 · filed May 28, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$173K
Net Open-Market Flow
-$173K
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 28, 2026Gift(G)395K—$00
May 28, 2026Gift(G)395K—$0695K
May 26, 2026Sell(S)21K$8.20$173K2.6M

Transaction Codes

G
Gift
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-26-067485) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML